CCO 公开
[search 0]
更多

Download the App!

show episodes
 
C
CCOHS Podcasts

1
CCOHS Podcasts

Canadian Centre for Occupational Health and Safety (CCOHS)

Unsubscribe
Unsubscribe
每月
 
CCOHS produces monthly podcasts on a wide variety of topics related to workplace health and safety. Each episode is designed to keep you current with information, tips and insights into the health, safety and well-being of working Canadians. You can download the audio segment to your computer or MP3 player and listen to it at your own convenience.!
 
The New CCO podcast from Page tells stories that explore the evolution of the CCO. From culture change to digital transformation to corporate purpose, we focus on the issues that matter to today's communications leaders. Page is the world’s premier membership organization for chief communications officers, PR agency CEOs and educators who seek to enrich the profession and improve corporate reputation management.
 
Este programa tiene como objetivo acercar la realidad de la acción sindical a un número cada vez mayor de personas, de manera que la ciudadanía cuente con información directa y de primera mano sobre esta actividad. Se desarrollará tanto la faceta más laboral del sindicato (información sobre conflictos, convenios, salud laboral, igualdad de oportunidades, negociación colectiva, resolución de dudas laborales,...) como su papel más sociopolítico (movilización social, relación con el tejido asoc ...
 
Loading …
show series
 
In this episode, Jill Blumenthal, MD, MAS, and Jennifer Cocohoba, PharmD, share how they manage possible antiretroviral (ARV)-associated toxicities in transgender individuals, including: Strategies on how to approach different ARV-related toxicities Other factors to consider when assessing possible ARV-related toxicities (eg, weight gain, cardiovas…
 
This podcast episode is part of a multimedia program discussing the impact of health disparities in anemia of chronic kidney disease (CKD) on patient outcomes. Tune in to hear Santosh Saraf, MD, and Milda Saunders, MD, MPH, highlight mitigation strategies to improve screening and management. The overview will include: The definition of CKD and the …
 
In this episode, Greg W. Mattingly, MD, and Vladimir Maletic, MD, have a conversation about the ongoing bipolar disorder research and developments expected to have an impact in the coming year. They elaborate on the various neurotransmitters being investigated and how this research might change the future of patient care. From investigating new mec…
 
In this episode, Prof Isabelle Ray Coquard, MD, PhD, and Ignace Vergote, MD, PhD, share their thoughts on key studies of interested presented at the 2022 ESGO annual meeting in Berlin, Germany, including: • Phase III CALLA trial of durvalumab combined with and following chemoradiotherapy in locally advanced cervical cancer • Geneva HRD test: valida…
 
In this episode, Iskandar Azwa, MBChB, and patient advocate Andrew Tan Tze Tho discuss barriers to genuinely patient-centered HIV care in Malaysia and the surrounding region and offer calls to action for healthcare professionals for responding to patient preferences. They discuss health literacy programs and other forms of effective health communic…
 
In this episode, Stefan Zeuzem, MD, discusses new viral hepatitis data from AASLD 2022, including: Hepatitis B Prevention of HBV vertical transmission when HBIg is unavailable Therapeutic vaccination for HBV cure Antiviral therapy to prevent HCC in patients with CHB in the indeterminate phase Hepatitis delta HDV prevalence in ethnically diverse, ur…
 
Get answers to the questions that you and your colleagues have asked! In this episode, Jonathan M. Meyer, MD; Leslie Citrome, MD, MPH; and Stuart Isaacson, MD, provide answers to audience questions that were submitted at recent CCO Psychiatry meetings. Their thoughtful responses cover your questions on screening, communicating with patients, medica…
 
In this episode, Nancy Reau, MD, shares her thoughts on the most practice-changing viral hepatitis data from AASLD 2022, including: Novel therapeutics for HBV HCV management strategies HDV screening and linkage to care Fatty liver disease in persons with viral hepatitis Use of statins to decrease morbidity and mortality in persons with liver diseas…
 
In this episode, Marion Elligsen, BScPhm, MSc, RPh, ACPR; Keith S Kaye, MD, MPH; and Andrew Shorr, MD, MPH, MBA, discuss key considerations for selecting empiric antibiotic regimens in patients with HABP/VABP in the intensive care unit, including: The role of novel β-lactam/β-lactamase inhibitor combinations Use of clinical predictions scores (eg, …
 
In this episode, Chloe Orkin, MBChB, FRCP, MD, and Babafemi Taiwo, MBBS, discuss new HIV data presented at IDWeek and HIV Glasgow 2022, including Prevention strategies LA therapies Investigational agents Presenters: Chloe Orkin, MBChB, FRCP, MD Professor of HIV Queen Mary, University of London Consultant Physician Lead for HIV Research Barts Health…
 
In this episode, activist and breast cancer survivor Yee Won Chong shares his experience as a transmasculine person navigating the healthcare system with Norma Steiner, MD, a gynecologic oncologist, who in turn offers her perspective on caring for patients across the gender spectrum. Topics include: 4 aspects of transgender care: emotional, social,…
 
In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and COVID-19 rebound phenomenon, including: EPIC-HR study of nirmatrelvir plus ritonavir PINETREE study of remdesivir MOVe-OUT and Panoramic studies of molnupiravir COVID-19 rebound in trea…
 
In this episode, Princy N. Kumar, MD, and Paul E. Sax, MD, discuss new COVID-19 data from IDWeek 2022, including: COVID-19 vaccines, including omicron BA.1 bivalent booster Risk factors for breakthrough COVID-19 infections COVID-19 diagnostics, including digital droplet PCR COVID-19 therapeutics, including: Nirmatrelvir plus ritonavir Tixagevimab p…
 
In this episode, Nneka Holder, MD, MPH, shares various strategies to improve meningococcal vaccine uptake in adolescent patients, including: Use of school vaccine mandates beyond entry requirements Promote more frequent visits by incorporating immunization platforms and using text or email reminders to bring patients back to the office Schedule fol…
 
The number of workers in Canada who are also caregivers is on the rise. Here’s how workplaces can provide support. Released: November 16, 2022 File Size: 9 MB Length: 17:57 minutes ------------------------- > Le nombre de travailleurs canadiens qui sont également des aidants naturels augmente. Voici comment les lieux de travail peuvent vous aider. …
 
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses solutions to expanding PrEP uptake. His discussion includes: Potential healthcare profe…
 
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses PrEP uptake for cisgender women. His discussion includes: Prevalence of PrEP use in cis…
 
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, focuses on transgender women. His discussion includes: Barriers to PrEP uptake in transgender wom…
 
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake for people who inject drugs. His discussion includes: PrEP upta…
 
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake in the context of racial inequities, specifically for Black and…
 
This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US.” Hear from Thuan Vu, MD, as he discusses linkage to care after HBV diagnosis in Asian communities from a provider’s perspective. And listen to discussions with Jennifer Wild, MSN, BSN, RN, OCN, and M…
 
In this episode, Paul E. Sax, MD, discusses long-acting (LA) injectables for HIV treatment, including: Guidance on the use of LA cabotegravir (CAB) + rilpivirine (RPV) Risk factors for virologic failure of LA CAB + RPV The ATLAS-2M study Combined clinical trials of LA CAB + RPV Practical considerations for LA CAB + RPV Implementation of LA CAB + RP…
 
In this episode, Paul E. Sax, MD, discusses the latest recommendations and options for HIV pre-exposure prophylaxis (PrEP), including: CDC PrEP guideline 2021 updates for oral PrEP The ANRS IPERGAY study: on-demand oral emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) PrEP in men who have sex with men who are at high risk for HIV infection A…
 
In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD​, discusses strategies for and importance of HIV care engagement and reengagement for those who have fallen out of care. Her overview includes: WHO Global Health Strategy on HIV Longitudinal HIV care trajectories Promotion of successful care and antiretroviral therapy (ART) adheren…
 
This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US.” First, Melinda Tran discusses treatment and retention of HBV care in Asian Communities in the US with Jennifer Wild, MS, BSN, RN, OCN, and Thuan Vu, MD. Their conversation offers an interesting mix …
 
Patient advocate Bright Ansah shares some issues he encountered while seeking treatment after his diagnosis with HBV, including limited follow-up on lab results and a lack of compassion from his healthcare providers, and rushed health appointments. Bright’s story opens up a conversation about broader concerns about HBV treatment and retention in ca…
 
Listen as patient advocate William Amiteye uses his own experience as a Tanzanian immigrant to discuss important barriers to effective HBV screening and diagnosis, including limited knowledge about HBV from his healthcare providers, a lack of compassion toward his diagnosis from those same providers, and a limited awareness of HBV from patients in …
 
In this episode, Renslow Sherer, MD, and Jason E. Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, discuss patient cases that illustrate key concepts for managing ambulatory patients with acute COVID-19 infection, including: A young, otherwise healthy patient An older patient with multiple comorbidities A patient with immunocompromise A patient requir…
 
In this episode, Farrukh T. Awan, MD, and Nicole Lamanna, MD, answer questions from an audience of healthcare professionals on topics related to the use of BTK inhibitors for the management of chronic lymphocytic leukemia (CLL). The topics covered include: Whether it is justifiable to use chlorambucil plus obinutuzumab as a control arm in a registr…
 
This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake for adolescents. His discussion includes: How PrEP is underused…
 
The CCO role is one of the most dynamic in the C-suite, requiring a swiss army knife of skillsets. Because of that, there are many different paths to the top of the communications function and we find that fascinating. In this episode, we sat down with Brian Lott, Page Chair and CCO at Mubadala about how his unlikely start in midwestern U.S. politi…
 
An RSV vaccine, if approved, may reduce disease burden in older adults. In this recap of the most common questions from a symposium at the Family Medicine Experience 2022 conference, listen as we discuss when an RSV vaccine may be approved and how to overcome barriers to the implementation of vaccines for older adults in primary care settings. Hear…
 
In this episode, hear Marta Boffito, MD, PhD, FRCP, and Julian Falutz, MD, FRCPC, discuss their approach to minimizing antiretroviral (ARV)-related intolerances in older patients with HIV, including: Consequences of polypharmacy Deprescribing ARV and non-ARV medications Complications associated with aging (eg, geriatric syndromes such as falls, fra…
 
In this episode, Marc Thompson and Tristan J. Barber, MA, MD, FRCP, discuss some of the barriers to genuinely patient-centered HIV care in the United Kingdom and offer calls to action for healthcare professionals for responding to patient preferences. They discuss barriers to HIV testing and effectively communicating the benefits of testing to disp…
 
In this episode, Deondre Moore and Samantha V. Hill, MD, MPH, discuss some of the barriers to genuinely patient-centered HIV care in the United States and offer calls to action for healthcare professionals for responding to patient preferences. They talk through some of the barriers that patients face, from struggling with unfamiliar medical termin…
 
In this episode, Joseph F. Goldberg, MD, and Roger McIntyre, MD, FRCPC, shed light on the symptom improvement timeline in bipolar depression. This is a topic made more complex when factoring in individual patient characteristics and comorbidities, but the 2 experts have astute insights on how to tailor a management plan based on such factors. They …
 
In this episode, Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, discusses closing the HIV pre-exposure prophylaxis (PrEP) gap for Black cisgender women, including: Racial inequities in PrEP access Addressing barriers to PrEP for cisgender women such as lack of education and awareness, low perceived risk of HIV, healthcare professional bias, and med…
 
In this episode, Christopher R. Flowers, MD, MS, and Kami Maddocks, MD, discuss their choices of recent important trials presented at the Society of Hematologic Oncology 2022 Annual Meeting evaluating the use of BTK inhibitors in chronic lymphocytic leukemia and mantle cell lymphoma. The discussion includes analyses of: GLOW: phase III randomized t…
 
In this podcast episode, Robert O. Cotes, MD, and Jonathan M. Meyer, MD, discuss tardive dyskinesia from identification to follow-up and ongoing management. They provide valuable insights on pharmacologic options to both consider and avoid to optimize outcomes in patients with tardive dyskinesia, including a focus on clinical strategies for use of …
 
In this episode, Latesha Elopre, MD, MSPH, discusses closing the HIV pre-exposure prophylaxis (PrEP) gap for Black men who have sex with men (MSM), including: Racial inequities in PrEP access Considering strategies to address barriers to PrEP uptake and persistence among Black MSM Considering individualized PrEP options On-demand oral emtricitabine…
 
When it comes to managing older adults with hepatitis B virus (HBV), what comorbidity, comedication, and adherence issues should be considered? Listen as Graham R. Foster, FRCP, PhD, discusses these considerations and more for strategizing the monitoring and treatment of older adults with HBV. Presenter: Graham R. Foster, FRCP, PhD Professor of Hep…
 
At a time when reality and satire are becoming increasingly indistinguishable, it is easy to see why disinformation can be so hard to detect. To dissect the various types of disinformation and identify the role business plays in helping tell the truth, we sat down with journalist Vivian Schiller, Executive Director of Aspen Digital, who is focused …
 
In this podcast episode from Clinical Care Options, Paul G. Richardson, MD; Natalie S. Callander, MD; and Noopur Raje, MD, answer questions from a live webinar on therapeutic options currently available for patients with relapsed/refractory multiple myeloma. The topics covered include: How to sequence currently available therapies after relapse Cha…
 
In this episode,Susana Banerjee, MBBS, MA, PhD, and Mansoor Raza Mirza, MD, share their thoughts on key studies of interested presented at the IGCS 2022 Annual Global Meeting for ovarian and cervical cancers including: Post-hoc analyses from SOLO-3: olaparib vs physician’s choice chemotherapy in germline BRCA mutant platinum-sensitive recurrent ova…
 
In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including: Rapid antigen tests and PCR tests Risk stratification of patients who have a positive SARS-CoV-2 test Antiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupirav…
 
In this episode, Timothy J. Wilkin, MD, MPH, provides a case-based overview of switching antiretroviral therapy in a patient with viral suppression on their current regimen who has a history of virologic failure with drug-resistance mutations. Key findings from 2 relevant studies—the SWITCHMRK trial and Study 380-4030—are reviewed. The case discuss…
 
In this episode, Tristan J. Barber, MA, MD, FRCP, and Darcy Wooten, MD, discuss switching ART with virologic suppression, including: Switching with prior or unknown resistance Data on switching to BIC/FTC/TAF with a preexisting M184V/I mutation from a pooled analysis of 6 phase III studies The impact of baseline resistance on outcomes following a s…
 
In this episode, Lilian Abbo, MD, FIDSA; Julie Ann Justo, PharmD, MS; and David van Duin, MD, PhD, FIDSA, FAST, discuss key concepts about extraintestinal pathogenic Escherichia coli, including: Diverse strains and virulence factors associated with invasive disease Antimicrobial resistance profiles seen in clinical practice Various disease manifest…
 
Loading …

快速参考指南

Google login Twitter login Classic login